Koyfin Home > Directory > Health Care > Acorda Therapeutics > Cash and Short-Term Investments

Acorda Therapeutics Cash and Short-Term Investments Chart (ACOR)

Acorda Therapeutics annual/quarterly Cash and Short-Term Investments from 2010 to 2020.
  • Acorda Therapeutics Cash and Short-Term Investments for the quarter ending June 06, 2020 was $66m a -283.65% decrease of -187m year over year
  • Acorda Therapeutics Cash and Short-Term Investments for the last 12 months ending June 06, 2020 was $66m a -283.65% decrease of -187m year over year
  • Acorda Therapeutics Annual Cash and Short-Term Investments for 2019 was $126m a -254.07% decrease of -320m from 2018
  • Acorda Therapeutics Annual Cash and Short-Term Investments for 2018 was $446m a 31.08% increase of 138m from 2017
  • Acorda Therapeutics Annual Cash and Short-Term Investments for 2017 was $307m a 48.37% increase of 149m from 2016
Other Balance Sheet Metrics:
  • Acorda Therapeutics Total Assets for the quarter ending December 12, 2018 was $1,300m a 8.66% increase of 113m year over year
  • Acorda Therapeutics Other Liabilities for the quarter ending December 12, 2018 was $204m a 10.59% increase of 22m year over year
  • Acorda Therapeutics Total Equity for the quarter ending December 12, 2018 was $612m a 10.14% increase of 62m year over year
View Chart On Koyfin

Quarterly ACOR Cash and Short-Term Investments Data

06/2020$66m
03/2020$83m
12/2019$126m
09/2019$253m
06/2019$297m
03/2019$343m
12/2018$446m
09/2018$461m
06/2018$392m
03/2018$333m

Annual ACOR Cash and Short-Term Investments Data

2019$126m
2018$446m
2017$307m
2016$159m
2015$353m
2014$308m
2013$274m
2012$234m
2011$296m
2010$240m